Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor

Chem Biol Interact. 2019 Feb 1:299:52-58. doi: 10.1016/j.cbi.2018.11.024. Epub 2018 Nov 28.

Abstract

Hypertension is a civilization disease leading to remodeling and damage of blood vessels, impaired renal function and premature death. The aim of this study was to compare the effect of chronic administration of URB597, the FAAH (fatty acid amide hydrolase) inhibitor, to rats with primary (SHRs) and secondary (DOCA-salt hypertensive rats) hypertension on electrical and physicochemical properties of kidney cells membranes. Changes in the electrical charge of the membrane may affect the cell functions. The electrical properties of the kidney cells (surface charge density, zeta potential) were measured by electrophoresis. Qualitative and quantitative composition of the membrane (phospholipids and proteins) was determined by HPLC and lipid peroxidation product (4-hydroxy-2E-hexenal; 4-HHE) level was examined by GCMSMS, while the sialic acid content was measured by resorcinol method. In rats with primary hypertension (SHR) and secondary hypertension (DOCA-salt), changes in electrical properties (increase of electric charge and zeta potential) and membrane composition (increase in sialic acid and protein concentration and decrease in phospholipid level) of kidney cells are observed in comparison to control animals. Greater changes were observed in DOCA-salt hypertensive rats. Changes in membrane properties caused by URB597 depend on the type of hypertension. The administration of URB597 to rats with primary hypertension partially prevents changes in the electrical properties (electrical charge, zeta potential) of the membrane caused by hypertension as well as in the sialic acid and proteins content. However, there is no reduction in oxidative stress, assessed by the level of 4-HHE, which may affect the metabolic function of the kidneys. URB597 administered to rats with DOCA salt does not prevent, but rather intensifies, changes caused by hypertension in the kidney. In conclusion, URB597 given to individuals with hypertension, particularly with secondary hypertension, enhancing some disturbances in electric and physicochemical properties of kidney cells observed in hypertension what may lead to additional kidney disorders. Therefore, further researches are necessary.

Keywords: Electrical properties; Hypertension; Kidney; Membrane composition; URB597.

MeSH terms

  • Amidohydrolases / antagonists & inhibitors*
  • Amidohydrolases / metabolism
  • Animals
  • Benzamides / pharmacology
  • Benzamides / therapeutic use*
  • Carbamates / pharmacology
  • Carbamates / therapeutic use*
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Chromatography, High Pressure Liquid
  • Desoxycorticosterone Acetate / pharmacology
  • Disease Models, Animal
  • Enzyme Inhibitors / therapeutic use*
  • Hypertension / drug therapy*
  • Hypertension / pathology
  • Kidney / cytology
  • Lipid Peroxidation / drug effects
  • Male
  • N-Acetylneuraminic Acid / analysis
  • Phospholipids / analysis
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar

Substances

  • Benzamides
  • Carbamates
  • Enzyme Inhibitors
  • Phospholipids
  • cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester
  • Desoxycorticosterone Acetate
  • Amidohydrolases
  • fatty-acid amide hydrolase
  • N-Acetylneuraminic Acid